South Africa’s private healthcare sector is under mounting pressure to balance affordability, quality, and long-term sustainability. Rising claims from preventable and lifestyle-related diseases—such as diabetes, cardiovascular disease, and cancer—are driving up healthcare costs for medical schemes and insurers, while hospitals face the growing challenge of reducing avoidable admissions and improving patient outcomes. In this environment, preventive medicine has emerged as both a clinical and commercial imperative.
For medical schemes, prevention represents an opportunity to bend the cost curve by shifting focus from reactive care to proactive health management. For hospital groups, it offers pathways to align with global value-based care principles and to strengthen continuity of care across the patient journey. For independent GPs, prevention enhances practice sustainability by positioning them as long-term wellness partners, not just curative service providers. Meanwhile, the pharmaceutical industry has begun to extend its value proposition beyond treatment toward early detection, vaccination, digital health, and behavioural change solutions.
With the National Health Insurance (NHI) reform on the horizon, the private sector’s role in building a preventive ecosystem that complements national objectives is more critical than ever. The Preventive Medicine Conference to be held on the 27th March 2026 provides a first-of-its-kind platform for the South African private healthcare industry to align commercial interests with population health outcomes. It will showcase evidence-based strategies, innovation, and partnership models that make prevention profitable, scalable, and sustainable—turning good medicine into good business.